Some investors look at (NYSE: PFE) as a has-been. That's understandable in some ways. Sales for the company's once-formidable COVID-19 franchise have tanked. So have Pfizer's overall revenue, profits, and share price.

However, there's an argument that Pfizer is more of a "will-be" than a has-been. Could the drugmaker even be a trillion-dollar stock by 2035?

The math is straightforward for how Pfizer could reach a market cap of $1 trillion over the next 11 or so years. Pfizer's market cap currently stands at close to $156 billion. To reach $1 trillion by the end of 2035, the stock would need to deliver an average compound annual growth rate of roughly 17.2%.

Continue reading

Source Fool.com